TWO SIGMA INVESTMENTS, LP - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 49 filers reported holding SOLENO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$28,000
-40.4%
149,546
-28.3%
0.00%
Q1 2022$47,000
-63.0%
208,546
-32.6%
0.00%
Q4 2021$127,000
-62.4%
309,546
-15.4%
0.00%
-100.0%
Q3 2021$338,000
+35.7%
365,846
+67.6%
0.00%0.0%
Q2 2021$249,000
-45.4%
218,252
-39.6%
0.00%0.0%
Q1 2021$456,000
-53.5%
361,530
-28.8%
0.00%
-66.7%
Q4 2020$980,000
-34.1%
507,618
-14.3%
0.00%
-40.0%
Q3 2020$1,487,000
+1289.7%
592,606
+1124.9%
0.01%
+400.0%
Q2 2020$107,00048,3800.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders